Search

Your search keyword '"Regenass, S"' showing total 241 results

Search Constraints

Start Over You searched for: Author "Regenass, S" Remove constraint Author: "Regenass, S"
241 results on '"Regenass, S"'

Search Results

2. A highly virulent variant of HIV-1 circulating in the Netherlands

3. Mining for pairs: shared clinic visit dates identify steady HIV‐positive partnerships

4. Population pharmacokinetic analysis of elvitegravir and cobicistat in HIV-1-infected individuals

5. Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimen

6. Assessing efficacy of different nucleos(t)ide backbones in NNRTI-containing regimens in the Swiss HIV Cohort Study

7. Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection

8. Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

9. Population pharmacokinetic modelling and evaluation of different dosage regimens for darunavir and ritonavir in HIV-infected individuals

10. Ageing with HIV: medication use and risk for potential drug–drug interactions

12. Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIRaben-1 subtype B and non-subtype B receiving a salvage regimen

13. Origin of Minority Drug-Resistant HIV-1 Variants in Primary HIV-1 Infection

14. Clustering of HCV coinfections on HIV phylogeny indicates domestic and sexual transmission of HCV

15. The Interplay Between Host Genetic Variation, Viral Replication, and Microbial Translocation in Untreated HIV-Infected Individuals

16. Ageing with HIV: medication use and risk for potential drug-drug interactions

17. Population pharmacokinetic modelling and evaluation of different dosage regimens for darunavir and ritonavir in HIV-infected individuals

18. Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 2012

19. Higher Risk of Incident Hepatitis C Virus Coinfection Among Men Who Have Sex With Men, in Whom the HIV Genetic Bottleneck at Transmission Was Wide

20. Hepatitis B Virus Infection Is Associated With Impaired Immunological Recovery During Antiretroviral Therapy in the Swiss HIV Cohort Study

21. Strong Impact of Smoking on Multimorbidity and Cardiovascular Risk Among Human Immunodeficiency Virus-Infected Individuals in Comparison With the General Population

22. Anti-apolipoprotein A-1 autoantibodies are associated with immunodeficiency and systemic inflammation in HIV patients

23. Assessing efficacy of different nucleos(t)ide backbones in NNRTI-containing regimens in the Swiss HIV Cohort Study

24. Ambulatory scintigraphic assessment of transient changes in left ventricular function: a new method for detection of silent myocardial ischaemia

25. Treatment-Naive Individuals Are the Major Source of Transmitted HIV-1 Drug Resistance in Men Who Have Sex With Men in the Swiss HIV Cohort Study

26. Treatment-Naive Individuals Are the Major Source of Transmitted HIV-1 Drug Resistance in Men Who Have Sex With Men in the Swiss HIV Cohort Study

27. Tuberculosis-related mortality in people living with HIV in Europe and Latin America: An international cohort study

28. Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIRaben-1 subtype B and non-subtype B receiving a salvage regimen

29. Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study

30. Increases in Condomless Sex in the Swiss HIV Cohort Study

31. Non-AIDS defining cancers in the D:A:D Study--time trends and predictors of survival: a cohort study

32. Incident Hepatitis C Virus Infections in the Swiss HIV Cohort Study: Changes in Treatment Uptake and Outcomes Between 1991 and 2013

33. Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIRaben-1 subtype B and non-subtype B receiving a salvage regimen

34. Generation of a Recombinant Gag Virus-Like-Particle Panel for the Evaluation of p24 Antigen Detection by Diagnostic HIV Test

35. Obesity Trends and Body Mass Index Changes After Starting Antiretroviral Treatment: The Swiss HIV Cohort Study

36. Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries

37. Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equations

38. Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries

39. Short- and long-term mortality and causes of death in HIV/tuberculosis patients in Europe

40. The interplay between host genetic variation, viral replication and microbial translocation in untreated HIV-infected individuals

41. Incident Hepatitis C Virus Infections in the Swiss HIV Cohort Study : changes in treatment uptake and outcomes between 1991 and 2013

42. Increases in condomless sex in the Swiss HIV Cohort Study.

43. Strong impact of smoking on multimorbidity and cardiovascular risk among human immunodeficiency virus-infected individuals in comparison with the general population.

44. Decreasing proportion of recent infections among newly diagnosed HIV-1 cases in Switzerland, 2008 to 2013 based on line-immunoassay-based algorithms

46. Missed opportunities among HIV-positive women to control viral replication during pregnancy and to have a vaginal delivery

47. Expansion of interferon-γ-secreting HIV-specific T cells during successful antiretroviral therapy

48. Health care index score and risk of death following tuberculosis diagnosis in HIV-positive patients

50. Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study

Catalog

Books, media, physical & digital resources